SCHEMBL4603376

SCHEMBL4603376

OCCCOCC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109731 0.95 MEN1 (0.39)
SCHEMBL13096717 0.92 TSHR (0.41)
SCHEMBL16640337 0.90 GBA1 (0.44)
SCHEMBL322260 0.86
SCHEMBL4614051 0.86 TSHR (0.47)
SCHEMBL7512016 0.84 TDP1 (0.36)
SCHEMBL10072541 0.84 TSHR (0.61)
SCHEMBL18902542 0.83 TSHR (0.50)
SCHEMBL1164544 0.81 GBA1 (0.49)
SCHEMBL2683407 0.81 TSHR (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180119063-A1 LEUCO POLYMERS AS BLUING AGENTS IN LAUNDRY CARE COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2018-05-03 US disclosed
EP-1438295-B1 AZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM MERCK SERONO SA (CH) 2012-08-15 EP disclosed
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed